Palbociclib-D8 is the 2H-labeled form of Palbociclib. Palbociclib (T1785) is an orally active CDK inhibitor that inhibits CDK4 and CDK6 (IC50=11/16 nM). Palbociclib (T1785) has anti-tumor activity and is used in research for estrogen receptor-positive and HER2-negative breast cancer.
Molecular Weight:
455.58
CAS Number:
[1628752-83-9]
Formula:
C24H21D8N7O2
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted
